Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Blue Owl Capital Inc (NY: OWL )

17.45 +0.08 (+0.46%)
Streaming Delayed Price Updated: 11:09 AM EDT, Aug 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Blue Owl Capital Inc

< Previous 1 2 3 4 Next >
The Speculative Dividend Stock To Buy For 2022
The big question is whether Blue Owl can live up to its earnings and dividend growth projections. Blue Owl is a brand-new investment management company with only one quarter as a publicly traded stock... 
Via Talk Markets
NBA's Atlanta Hawks Valued At $2B: How You Can Own A Stake And What It Means For Knicks' Owner MSGS
Valuations for professional sports teams continue to rise. A rule that allows private equity companies to own minority stakes in National Basketball Association (NBA) teams... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021
Upgrades According to Wells Fargo, the prior rating for Douglas Emmett Inc (NYSE: 
Via Benzinga
10 Asset Management Stocks to Buy to Ride Out Omicron
Star portfolio manager Rajiv Jain sold 20% of his firm to investors. In general, asset management stocks are solid picks. Here are ten to buy. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
Upgrades For CarMax Inc (NYSE: 
Via Benzinga
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... 
Via Benzinga
Unusual Options Activity Insight: Blue Owl Capital
Blue Owl Capital (NYSE:OWL) shares experienced unusual optio... 
Via Benzinga
November SPAC Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch
The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals. SPAC merger votes can act as a catalyst,... 
Via Benzinga
Want To Own A Piece Of The Phoenix Suns? This Former SPAC Owns A Stake, Could Own More NBA Stakes Soon
The Phoenix Suns are nearing an NBA Championship for the 2020-2021 season, which would be the first title in team history. The Suns are majority-owned by Robert Sarver, but... 
Via Benzinga
12 Financials Stocks Moving In Monday's Pre-Market Session
Gainers Broadway Financial (NASDAQ:BYFC) stock moved upwards by 9.12% to $3.35 during Monday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program.... 
Via Benzinga
Why Shares of Blue Owl Capital Are Falling Heading Into the Weekend
The stock got off to a good start today after receiving a buy rating from an analyst, but then dipped. 
Via The Motley Fool
12 Financials Stocks Moving In Friday's Intraday Session
Gainers DEP SHR RP I PREF ST (NASDAQ:HBANM) stock increased by 132.03% to $26.22 during Friday's regular session. The current volume of 9.6K shares is 2377.34% of DEP... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... 
Via Benzinga
30 Stocks Moving In Friday's Mid-Day Session
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares jumped 105.4% to $54.23 after the company announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401,... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle... 
Via Benzinga
48 Biggest Movers From Friday
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.